Shandong Pharmaceutical Glass Co.Ltd (SHA:600529)

SHA:600529 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	2,281	1,074	1,065	1,466	1,352	885.04
Trading Asset Securities	502.24	1,671	1,725	1,218	1,101	307.13
Cash & Short-Term Investments	2,783	2,745	2,790	2,684	2,453	1,192
Cash Growth	5.13%	-1.62%	3.95%	9.40%	105.80%	-12.49%
Accounts Receivable	1,475	1,486	1,732	1,701	1,551	1,200
Other Receivables	2.02	2.06	1.87	1.78	2.24	3.38
Receivables	1,477	1,489	1,734	1,703	1,553	1,203
Inventory	1,734	1,696	1,279	1,055	1,210	877.74
Other Current Assets	131.47	82.88	177.99	103.8	104.63	61.99
Total Current Assets	6,126	6,012	5,980	5,546	5,321	3,335
Property, Plant & Equipment	3,586	3,678	3,786	3,465	2,821	2,557
Long-Term Investments	0.05	0.05	0.05	0.05	0.05	0.05
Other Intangible Assets	253.76	241.97	247.24	253.67	260.37	198.37
Long-Term Deferred Tax Assets	92.88	91.79	74.46	37.8	32.01	32.42
Other Long-Term Assets	70.23	19.79	51.73	16.79	349.91	287.01
Total Assets	10,128	10,044	10,140	9,319	8,784	6,410

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1,046	1,208	1,583	1,394	1,418	1,436
Accrued Expenses	60.44	211.77	209.47	149.8	130.47	126.18
Short-Term Debt	-	-	-	1.83	5.2	-
Current Portion of Leases	-	14.11	-	-	-	-
Current Income Taxes Payable	17.45	8.68	30.25	16.65	14.87	15.25
Current Unearned Revenue	46.69	56.65	60	61.79	51.04	74.61
Other Current Liabilities	253.35	101.96	118.07	102.83	144.13	27.74
Total Current Liabilities	1,440	1,601	2,001	1,727	1,764	1,679
Long-Term Leases	22.77	23.4	-	-	-	-
Long-Term Unearned Revenue	119.91	124.53	131.67	57.62	58.95	59.97
Total Liabilities	1,583	1,749	2,132	1,784	1,823	1,739

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	663.61	663.61	663.61	663.61	663.61	594.97
Additional Paid-In Capital	2,687	2,687	2,687	2,687	2,687	913.45
Retained Earnings	5,134	4,882	4,591	4,112	3,535	3,096
Comprehensive Income & Other	61.37	61.81	66.39	71.59	75.48	66.22
Total Common Equity	8,546	8,295	8,008	7,535	6,962	4,670
Shareholders' Equity	8,546	8,295	8,008	7,535	6,962	4,670
Total Liabilities & Equity	10,128	10,044	10,140	9,319	8,784	6,410

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	39.39	37.5	-	1.83	5.2	-
Net Cash (Debt)	2,744	2,708	2,790	2,682	2,448	1,192
Net Cash Growth	3.64%	-2.96%	4.02%	9.56%	105.36%	-12.49%
Net Cash Per Share	4.14	4.08	4.20	4.05	4.08	2.00
Filing Date Shares Outstanding	656.45	663.61	663.61	663.61	663.61	594.97
Total Common Shares Outstanding	656.45	663.61	663.61	663.61	663.61	594.97
Working Capital	4,685	4,411	3,980	3,819	3,557	1,656
Book Value Per Share	13.02	12.50	12.07	11.35	10.49	7.85
Tangible Book Value	8,292	8,053	7,761	7,281	6,701	4,472
Tangible Book Value Per Share	12.63	12.13	11.69	10.97	10.10	7.52
Buildings	-	2,271	2,149	1,911	1,507	1,402
Machinery	-	3,632	3,426	2,745	983.08	2,004
Construction In Progress	-	71.04	215.36	470.14	475.18	342.58

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 25, 2026

Data Sources Report a data error